Ghana to receive AstraZeneca Covid-19 Vaccines by the end of February.
Ghana is expected to receive about 2.4 million initial doses of the AstraZeneca COVID-19 vaccine by end of February 2021 under the UN COVAX facility, it has been announced.
President Nana Addo Dankwa Akufo-Addo in his 23rd national update on measures taken by government to curb the COVID-19 pandemic in Ghana announced plans to procure 17.6 million doses of COVID-19 vaccine by the end of June with the first doses arriving in March.
According to the President, “Our aim is to vaccinate the entire population, with an initial target of 20 million people.”
The distribution forecast published by the COVAX facility on Wednesday, February 3, 2021, stated that the arrangement is expected to cover at least 3 per cent of Ghana’s population.
It said the arrangement was part of 240 million doses of the AstraZeneca/Oxford vaccines licensed to the Serum Institute of India (SII) which have been earmarked for initial distribution to countries signed unto the COVAX facility.
According to the distribution forecast by COVAX, based on the limited quantity of doses available, the list of participants was pared down via a WHO-led review process based on four factors including the country’s readiness, as well as an assessment of risk of health care worker exposure.